Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Turner Syndrome to Genetic Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Turner Syndrome to Genetic Disorders Clinical Trials 20
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Turner Syndrome Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profile Snapshots 35
Appendix 68
Abbreviations 68
Definitions 68
Research Methodology 69
Secondary Research 69
About GlobalData 69
Contact Us 70
Source 70

List of Tables
Turner Syndrome Therapeutics, Global, Clinical Trials by Region, 2018* 7
Turner Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Turner Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Turner Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Turner Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Turner Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Turner Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14
Turner Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Turner Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 17
Turner Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Turner Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Turner Syndrome to Genetic Disorders Clinical Trials, E7 Countries (%), 2018* 21
Turner Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Turner Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Turner Syndrome Therapeutics, Global, Clinical Trials by Phase, 2018* 24
Turner Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 25
Turner Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Turner Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Turner Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Turner Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 29
Turner Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 31
Turner Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 33
Turner Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34

List of Figures
Turner Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Turner Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Turner Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Turner Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Turner Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Turner Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Turner Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14
Turner Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15
Proportion of Turner Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 16
Turner Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Turner Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Turner Syndrome to Genetic Disorders Clinical Trials, E7 Countries (%), 2018* 20
Turner Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 22
Turner Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 23
Turner Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2018* 24
Turner Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 25
Turner Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2018* 26
Turner Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27
Turner Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28
Turner Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 29
Turner Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30
Turner Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32
Turner Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34
GlobalData Methodology 69

Companies Mentioned
- Novo A/S
- Eli Lilly and Co
- E. Merck KG
- Ferring Holding SA
- LG Chem Ltd
- JCR Pharmaceuticals Co Ltd
- Ipsen SA
- GeneScience Pharmaceuticals Co Ltd
- F. Hoffmann-La Roche Ltd
- Dong-A Socio Group